Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the Smidt Heart Institute as director of Preventive Cardiology, associate director of the Preventive and Rehabilitative Cardiac Center and associate director of the Barbra Streisand Women’s Heart Center in the Department of Cardiology.
Claudia Huerta, 43, knows a thing or two about transformations. After being diagnosed with a serious, though common, heart condition called atrial fibrillation (AFib), the payroll manager and Maywood, California, resident transformed herself from being overweight and overstressed to being a lean, heart-healthy bodybuilding competition winner who is now medication free.
Lali Medina-Kauwe, PhD, former co-leader of the Cancer Biology Program in Cedars-Sinai Cancer, has assumed a new role as associate director for Basic Research.
Jeannea Jordan, who turns 80 in October, is a local sailing pioneer who began racing and cruising her 30-foot sailboat 25 years ago when few women were part of the sport. When a tumor on her spine ran her aground last year and her oncologist at another hospital couldn’t help, she found a neurosurgeon as dedicated as she is to get her back in the captain’s chair.
A study published today in the New England Journal of Medicine (NEJM) found that among patients with aortic stenosis undergoing transfemoral TAVR, the use of a debris capturing device called cerebral embolic protection reduced the risk of disabling stroke from 1.3% to 0.5%.
Vascular and cardiac surgeons in the Smidt Heart Institute at Cedars-Sinai know all too well the danger that looms when a patient experiences a tear in their heart’s main artery, called an aortic dissection. The condition, however, is often mistaken by patients—and even some physicians and nurses—for a heart attack, which can delay diagnosis and subsequent lifesaving surgery.
A study published today in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging shows that artificial intelligence tools can more rapidly, and objectively, determine calcium scores in computed tomographic (CT) and positron emission tomographic (PET) images than physicians, even when obtained from very-low-radiation CT attenuation scans.
A novel clinical trial from Cedars-Sinai Cancer shows that active surveillance is an effective treatment for many low-risk thyroid cancer patients. The study, published in JAMA Oncology, also showed for the first time that patients who opted for active surveillance experienced less anxiety than patients who underwent surgery.
The Cedars-Sinai Department of Computational Biomedicine has received an $8 million grant from the National Institutes of Health to study Alzheimer’s disease.
As a senior at Burbank High School, Keith Kasitz has his future ahead of him. But what he’s looking forward to right now is getting back to playing the sport he loves: football.
The Dhillon family seemed to be living the California dream, enjoying the waterway just steps from their home on Naples Island. But a little more than five years ago, when their daughter, Daya, began feeling ill, the Dhillon family’s California dream morphed into a medical nightmare.
Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.
Physicians and scientists from Cedars-Sinai will be attending and sharing research and clinical breakthroughs at the American Rhinologic Society Annual Meeting (ARS) taking place Sept. 9-10, the American Neurotology Society (ANS) “Super Saturday” Meeting Sept. 10, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting (AAO-HNSF22) taking place Sept. 10-14, in Philadelphia.
James Turkson, PhD, professor in the Division of Medical Oncology in the Department of Medicine at Cedars-Sinai, is uniquely positioned for a new role developed at Cedars-Sinai Cancer: director for Diversity, Inclusion and Strategy.
Racial and ethnic minorities in Los Angeles County are more likely to live as far as or farther than five miles from a cardiac rehabilitation facility, according to a new study by investigators at the Smidt Heart Institute at Cedars-Sinai.
Jill Martin has been tapped to lead the Cedars-Sinai Medical Network as its new executive vice president, effective Nov. 30.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Ali Azizzadeh, MD, an internationally recognized vascular surgeon at Cedars-Sinai, has been appointed associate dean of Faculty Affairs.
People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by investigators at Cedars-Sinai Cancer.
Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.
As Southern California endures the ongoing heatwave, Southern California Sam Torbati, MD, is available later today and throughout the holiday weekend to discuss how to avoid hot weather emergencies.
While the Los Angeles Rams quarterback Matthew Stafford works on his timing in the pocket, sports medicine specialists from Cedars-Sinai Kerlan-Kobe Institute—renowned for treating today's top professional athletes—are going through their reps to keep players healthy as they prepare to defend their championship title. Cedars-Sinai Kerlan-Jobe Institute specialists serve as the official team physicians for the Rams.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai has selected Pasy Wang as its inaugural vice president and chief investment officer. In this newly created leadership role, Wang will design and manage Cedars-Sinai's investment portfolio to support organizational growth and critical patient care for the community.
New research from the Smidt Heart Institute at Cedars-Sinai demonstrated that women—when height is accounted for—have a 50% higher risk of developing the abnormal heart rhythm disturbance when compared to men.
Following an extensive national search, Cedars-Sinai has appointed Cristina R. Ferrone, MD, as chair of the Department of Surgery. Currently a professor of Surgery at Harvard Medical School and director of the Office of Clinical Careers for Massachusetts General Hospital in Boston, Ferrone will assume her new position in January 2023.
Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer—at an early enough stage that cure is possible. Their work was published online in the peer-reviewed journal Hepatology.
During National Atrial Fibrillation (AFib) Awareness Month and Aortic Disease Awareness Week, Smidt Heart Institute cardiologists and surgeons are available for interviews with journalists working on stories about these common heart conditions.
Después de dos años y medio de vivir la pandemia de COVID-19, el próximo fin de semana largo puede sentirse como un respiro del constante estrés, comenta el Dr. Itai Danovitch MBA, presidente del Departamento de Psiquiatría y Neurociencias del Comportamiento de Cedars-Sinai.
Sheri Saenz is enjoying everyday pleasures as a Laguna Niguel grandmother, crafting and camping with her granddaughter and grandson and vacationing with her husband of 34 years.
In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
Monkeypox cases are on the rise in the U.S., stoking fear and confusion about the way the virus is spread, who is at risk and where to seek treatment.
Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the peer-reviewed journal Neurology, will ease the minds of individuals still hesitant to be vaccinated.
Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in the peer-reviewed journal Cell Reports, could lead to improved treatments for soft-tissue sarcomas.
After two and a half years of living through the COVID-19 pandemic, the upcoming long weekend can feel like a respite from the constant stress, says Itai Danovitch, MD, MBA, chair of Cedars-Sinai’s Department of Psychiatry and Behavioral Neurosciences.
The Cedars-Sinai Accelerator is welcoming 10 health-tech startup companies from around the world to its eighth accelerator class. The companies are building a variety of healthcare solutions—from culturally-appropriate digital mental health services to wearable devices that help patients manage chronic asthma.
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.
For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose Bisellach, RN, nurse manager in the Providence Cedars-Sinai Tarzana Medical Center Emergency Room, give their best advice for starting a successful school year.
Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute.
Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.
The majority of people who were likely infected with the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn’t know they had the virus, according to a new study from Cedars-Sinai investigators. The findings are published in JAMA Network Open.
Russell Secker, now 67, was in Lake Tahoe in 2016 to run a series of ultra-distance races with his wife, Claire. The two had completed hundreds of marathons and races totaling thousands of miles. But this time was different. A terrible headache and shortness of breath took Russell, a native of England, out of the running.
As baseball heads into the final weeks of the regular season, Cedars-Sinai has opened a special exhibit, "Take Me Out to the Ball Game, 100+ Years of Baseball Movies & Entertainment." It features hand-drawn posters of classic baseball-themed movies and, in all, consists of 35 items.
Marc Botnick, MD, a board-certified radiation oncologist with more than 20 years of experience managing all cancer types, has been named regional medical director for Radiation Oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise.
A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.
When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.
Adelynn Garza knows a thing or two about beating the odds.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
